title: Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL.
authors.forename: Jodie M
authors.initials: JM
authors.lastname: Fink
authors.forename: Donna L
authors.initials: DL
authors.lastname: Capozzi
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Shermock
authors.forename: Michael A
authors.initials: MA
authors.lastname: Militello
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Hutson
authors.forename: Matt E
authors.initials: ME
authors.lastname: Kalaycio
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Bolwell
mesh_terms: D000328:Adult; D002405:Catheterization, Central Venous; D004868:Equipment Failure; D006801:Humans; D010960:Plasminogen Activators / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator